DailyPharma | 05.09.2022 – 11:53
Humanization of clinical laboratories or building an observatory to disseminate current issues in laboratory medicine are some of the strategic lines of the Spanish Society of Laboratory Medicine’s (SEQCML) new 2022-2024 strategic plan and which aims to “make patients health improvement”.
The new project, developed over a period of eight months, was born with the aim of structuring the functions of the Board of Directors and SEQCML during this triennial. The strategic plan has been developed in several phases, involving a massive survey of members, and has been carried out thanks to the work of a committee of experts composed of members independent of the board of directors.
The new strategic plan envisages the implementation of a total of 50 actions and nine strategic lines. Among them, the president of SEQCML, Antonio Buono, highlights the Humaniza program. “We want to develop a humanization policy aimed at clinical laboratories in their pre-analytical phase and at the time of sample collection, to ensure humane care for patients, family members and peers,” he explains. .
A commitment to 5P medicine (individualized, predictive, preventive, participatory and population-based) and the promotion of patient-oriented care among scientific societies are also key pivots of the project. On the other hand, the new strategic plan is committed to the development of formulas of collaboration between laboratory experts and professionals of other specialties and to promote personalized medicine linked to molecular biology.
Similarly, it seeks to promote the specialties of laboratory medicine through various functions. Specifically, the objective is to carry out research projects through a multi-centre registry where a large number of laboratories participate, development of a channel of good practices and the launch of a SEQCML observatory “to monitor and disseminate current issues”. “Successful Experiences and Trends in Laboratory Medicine”, explains Dr. Antonio Bueno.
The Society also proposes the creation of a working group to assess the impact of the 2030 Agenda on Laboratory Medicine and identify measures that should be adopted to move towards a green laboratory.
The new strategic plan has explored many aspects for improvement and a series of obstacles to overcome. One of them is the lack of recognition of the contribution of laboratory medicine and the clinical laboratory to clinical and research work. In addition, there is an excessive demand for laboratory tests and increased spending, which, according to the president of SEQCML, can generate “a biased image of clinical laboratory and laboratory medicine among managers of hospitals or regional health services”. ,